Charlottesville, VA — October 29, 2004 —Diffusion Pharmaceuticals LLC, a pharmaceutical company which discovers and develops novel small-molecule therapeutics for the treatment of oxygen deficiency in tissues, today announced its selection as the winner of the Virginia’s Technology Capital Access Forum’s (VTCAF) business plan competition, receiving the $10,000 cash prize sponsored by Third Security, LLC. [...]

Charlottesville, VA — October 22, 2004 — Diffusion Pharmaceuticals LLC, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced its selection as one of ten finalists to present at the 2nd annual Virginia’s Technology Capital Access Forum (VTCAF) on Thursday, October 28, 2004, in Roanoke, Virginia. The two-day event at the [...]

CHARLOTTESVILLE, VA — Tuesday, September 7, 2004 — Diffusion Pharmaceuticals, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced it has been awarded a $1 million appropriation in the FY 2005 Defense Budget, which President Bush signed last month. These funds are allocated for studies to advance its lead compound, trans [...]

CHARLOTTESVILLE, VA — July 28, 2004 – Diffusion Pharmaceuticals LLC, a privately held early-stage pharmaceutical company discovering and developing novel small-molecule therapeutics to treat hypoxia (oxygen deprivation at the cellular level), today announced that it has completed a $2.1 million private equity round. These proceeds, along with a $1.2 million grant (N00014-04-C-0146) recently awarded to [...]

CHARLOTTESVILLE, VA — Tuesday, February 17, 2004 — Diffusion Pharmaceuticals LLC today announced that the company will present at the BIO CEO & Investor Conference Tuesday, February 24th, 2004, opening night, at the Waldorf Astoria in New York, New York. David G. Kalergis, JD/MBA, Chief Executive Officer of Diffusion Pharmaceuticals LLC, will provide an overview [...]